Newsroom

Sorted by: Latest

-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Saudi Arabia Construction Industry Databook 2025: Market Size & Forecast by Value & Volume Across Residential, Commercial, Industrial, Institutional, Infrastructure, City-Level Construction 2020-2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Saudi Arabia Construction Industry Databook Series - Market Size & Forecast by Value & Volume, 40+ Market Segments Across Residential, Commercial, Industrial, Institutional, Infrastructure, City-Level Construction by Value and Cost Structure, Q4 2025 Update" report has been added to ResearchAndMarkets.com's offering. According to the analyst, the construction market in Saudi Arabia is expected to grow by 6.2% on annual basis to reach SAR 232.14 billion in 2...
-

Charles Schwab Investment Management, Inc. UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Charles Schwab Investment Management, Inc. (CSIM) in its capacity as investment advisor to clients. CSIM expressly disclaims beneficial ownership of the shares described in this form 8.3. (b) Owner or controller of interests and short positions...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Deutsche Bank AG UK Regulatory Announcement: Buy-Back of Securities

LONDON--(BUSINESS WIRE)--  DB ETC plc COMPANY ANNOUNCEMENT Immediate Release 22 December 2025 Xtrackers Physical Gold ETC (EUR) (Incorporated and registered in Jersey under the Companies (Jersey) Law 1991 (as amended) with registered number 103781) Re: Buy-Back of ETC Securities Announcement The Issuer has agreed to buy back the ETC Securities for the following Series as set out in the table below. Series Number of Securities to be bought back Trade Date Settlement Date ISIN Series 04 - Xtracke...
-

Iran Cement Industry Report 2025: Cement Products, Distribution Channel, Market Share, Import/Export, End Market Dynamics 2020-2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Iran Cement Industry Size & Forecast by Value and Volume Across 80+ Market Segments by Cement Products, Distribution Channel, Market Share, Import - Export, End Markets - Databook Q4 2025 Update" report has been added to ResearchAndMarkets.com's offering. The cement market in Iran is expected to grow by 4.2% annually to reach US$4.74 billion in 2025. The cement market in the country recorded strong growth during 2020-2024, achieving a CAGR of 4.4%. Growth momen...
-

Deutsche Bank AG UK Regulatory Announcement: Value per Security

LONDON--(BUSINESS WIRE)--  DB ETC PLC Dated: 22 December 2025 COMPANY ANNOUNCEMENT Immediate Release 22 December 2025 DB ETC plc (the Issuer) (incorporated and registered in Jersey under the Companies (Jersey) Law 1991 (as amended) with registered number 103781) Re: Value per Security of ETC Securities Announcement The Issuer is providing the Value per Security for the ETC Securities for the following Series as set out in the table below for 19 December 2025 Series ISIN Currency Value per Secur...
-

Incyte Japan annonce l’autorisation de Zynyz® (rétifanlimab) pour le traitement de première intention du cancer anal avancé

TOKYO--(BUSINESS WIRE)--Incyte Biosciences Japan G.K. a annoncé aujourd’hui que le ministère japonais de la Santé, du Travail et des Affaires sociales (MHLW) avait approuvé Zynyz® (rétifanlimab) en association avec le carboplatine et le paclitaxel (chimiothérapie à base de platine) pour le traitement de première intention du carcinome épidermoïde avancé du canal anal (SCAC). « L’autorisation accordée aujourd’hui marque une étape importante pour les patients atteints d’un cancer anal avancé au J...